CS
ADPT icon

Credit Suisse’s Adaptive Biotechnologies ADPT Stock Holding History

Credit Suisse’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$465K Buy
144,726
+6,146
+4% +$23.8K ﹤0.01% 2668
2023
Q4 		$679K Buy
138,580
+11,019
+9% +$50.3K ﹤0.01% 2575
2023
Q3 		$695K Sell
127,561
-5,173
-4% -$34.2K ﹤0.01% 2500
2023
Q2 		$891K Buy
132,734
+10,133
+8% +$75.3K ﹤0.01% 2458
2023
Q1 		$1.08M Buy
122,601
+3,910
+3% +$34.5K ﹤0.01% 2275
2022
Q4 		$907K Buy
118,691
+20,304
+21% +$158K ﹤0.01% 2405
2022
Q3 		$700K Buy
98,387
+7,874
+9% +$74.2K ﹤0.01% 2577
2022
Q2 		$732K Buy
90,513
+2,720
+3% +$23.9K ﹤0.01% 2592
2022
Q1 		$1.22M Buy
87,793
+10,226
+13% +$161K ﹤0.01% 2417
2021
Q4 		$2.18M Sell
77,567
-9,519
-11% -$292K ﹤0.01% 2724
2021
Q3 		$2.96M Buy
87,086
+2,656
+3% +$96.1K ﹤0.01% 2508
2021
Q2 		$3.45M Buy
84,430
+4,767
+6% +$185K ﹤0.01% 2407
2021
Q1 		$3.21M Buy
79,663
+9,675
+14% +$524K ﹤0.01% 2464
2020
Q4 		$4.14M Buy
69,988
+2,995
+4% +$154K ﹤0.01% 2253
2020
Q3 		$3.26M Sell
66,993
-77,534
-54% -$3.26M ﹤0.01% 2067
2020
Q2 		$6.99M Buy
144,527
+136,523
+1,706% +$4.98M 0.01% 1499
2020
Q1 		$222K Buy
+8,004
New +$223K ﹤0.01% 3594
2019
Q3 		– Sell
-61,000
Closed -$2.95M – 4100
2019
Q2 		$2.95M Buy
+61,000
New +$2.7M ﹤0.01% 2165

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Credit Suisse's ADPT Position: Q1 2024 in Review

Credit Suisse increased its Adaptive Biotechnologies (ADPT) stake by 4.4% in Q1 2024, buying an estimated $23.8K and bringing the position to 144,726 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #2668.

Credit Suisse first reported a position in ADPT in Q2 2019 and has held it in 18 quarters since. The position peaked at $6.99M in Q2 2020. 190 funds tracked by Wall St. Rank hold ADPT as of Q1 2024.

  • Credit Suisse held 144,726 shares of Adaptive Biotechnologies worth $465K as of Q1 2024.
  • Credit Suisse bought 6,146 Adaptive Biotechnologies shares in Q1 2024, an estimated $23.8K.
  • Adaptive Biotechnologies made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2668 holding.
  • Credit Suisse first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 18 quarters since.
  • Credit Suisse's Adaptive Biotechnologies position peaked at $6.99M in Q2 2020.
  • 190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.